US 12,263,168 B2
Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation
Mark C. Siracusa, New Brunswick, NJ (US)
Assigned to RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, New Brunswick, NJ (US)
Filed by Rutgers, the State University of New Jersey, New Brunswick, NJ (US)
Filed on Jun. 30, 2022, as Appl. No. 17/855,501.
Application 17/855,501 is a division of application No. 16/940,677, filed on Jul. 28, 2020, granted, now 11,406,637.
Application 16/940,677 is a division of application No. 15/764,785, granted, now 10,758,537, issued on Sep. 1, 2020, previously published as PCT/US2016/046819, filed on Aug. 12, 2016.
Claims priority of provisional application 62/235,257, filed on Sep. 30, 2015.
Prior Publication US 2023/0149403 A1, May 18, 2023
Int. Cl. A61K 31/513 (2006.01); A61K 31/18 (2006.01); A61K 31/4184 (2006.01); A61K 31/423 (2006.01); A61K 31/433 (2006.01); A61K 31/451 (2006.01); A61K 31/505 (2006.01); A61K 31/542 (2006.01); A61K 31/7048 (2006.01); A61K 45/06 (2006.01); A61P 11/06 (2006.01)
CPC A61K 31/513 (2013.01) [A61K 31/18 (2013.01); A61K 31/4184 (2013.01); A61K 31/423 (2013.01); A61K 31/433 (2013.01); A61K 31/451 (2013.01); A61K 31/505 (2013.01); A61K 31/542 (2013.01); A61K 31/7048 (2013.01); A61K 45/06 (2013.01); A61P 11/06 (2018.01); A61K 2300/00 (2013.01)] 8 Claims
 
1. A method for treating allergic asthma comprising administering to a mammal in need thereof an effective amount of a carbonic anhydrase (Car) enzyme inhibitor wherein the Car enzyme inhibitor is methazolamide.